Eldelumab
From Infogalactic: the planetary knowledge core
Lua error in Module:Infobox at line 166: malformed pattern (missing ']').
Eldelumab is a monoclonal antibody designed for the treatment of Crohn's disease and ulcerative colitis.[1]
This drug was developed by Bristol-Myers Squibb.
References
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Eldelumab, American Medical Association.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Bristol-Myers Squibb
- Monoclonal antibodies
- Monoclonal antibody stubs
